Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13

Climb Bio, Inc. (NASDAQ: CLYM) reported Q3 EPS of ($0.13), versus $0.00 reported last year.

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Penguin Solutions closes $750M convertible notes offering due 2031
• Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.6% Yield